{
  "ticker": "CRL",
  "year": 2024,
  "quarter": 1,
  "last_updated": "2025-04-19T09:36:19.551340",
  "count": 229,
  "transactions": [
    {
      "id": 6603,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-03-08",
      "transaction_shares": "808",
      "transaction_price": "267.52",
      "transaction_type": "S",
      "shares_after_transaction": "7024"
    },
    {
      "id": 17533,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-03-08",
      "transaction_shares": "808",
      "transaction_price": "267.52",
      "transaction_type": "S",
      "shares_after_transaction": "7024"
    },
    {
      "id": 31243,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-03-08",
      "transaction_shares": "808",
      "transaction_price": "267.52",
      "transaction_type": "S",
      "shares_after_transaction": "7024"
    },
    {
      "id": 48955,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-03-08",
      "transaction_shares": "808",
      "transaction_price": "267.52",
      "transaction_type": "S",
      "shares_after_transaction": "7024"
    },
    {
      "id": 69221,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-03-08",
      "transaction_shares": "808",
      "transaction_price": "267.52",
      "transaction_type": "S",
      "shares_after_transaction": "7024"
    },
    {
      "id": 91655,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-03-08",
      "transaction_shares": "808",
      "transaction_price": "267.52",
      "transaction_type": "S",
      "shares_after_transaction": "7024"
    },
    {
      "id": 116310,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-03-08",
      "transaction_shares": "808",
      "transaction_price": "267.52",
      "transaction_type": "S",
      "shares_after_transaction": "7024"
    },
    {
      "id": 142854,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-03-08",
      "transaction_shares": "808",
      "transaction_price": "267.52",
      "transaction_type": "S",
      "shares_after_transaction": "7024"
    },
    {
      "id": 171459,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-03-08",
      "transaction_shares": "808",
      "transaction_price": "267.52",
      "transaction_type": "S",
      "shares_after_transaction": "7024"
    },
    {
      "id": 202620,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-03-08",
      "transaction_shares": "808",
      "transaction_price": "267.52",
      "transaction_type": "S",
      "shares_after_transaction": "7024"
    },
    {
      "id": 236108,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-03-08",
      "transaction_shares": "808",
      "transaction_price": "267.52",
      "transaction_type": "S",
      "shares_after_transaction": "7024"
    },
    {
      "id": 272632,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-03-08",
      "transaction_shares": "808",
      "transaction_price": "267.52",
      "transaction_type": "S",
      "shares_after_transaction": "7024"
    },
    {
      "id": 6609,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-03-04",
      "transaction_shares": "1750",
      "transaction_price": "260.88",
      "transaction_type": "S",
      "shares_after_transaction": "8832"
    },
    {
      "id": 17539,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-03-04",
      "transaction_shares": "1750",
      "transaction_price": "260.88",
      "transaction_type": "S",
      "shares_after_transaction": "8832"
    },
    {
      "id": 31249,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-03-04",
      "transaction_shares": "1750",
      "transaction_price": "260.88",
      "transaction_type": "S",
      "shares_after_transaction": "8832"
    },
    {
      "id": 48965,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-03-04",
      "transaction_shares": "1750",
      "transaction_price": "260.88",
      "transaction_type": "S",
      "shares_after_transaction": "8832"
    },
    {
      "id": 69231,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-03-04",
      "transaction_shares": "1750",
      "transaction_price": "260.88",
      "transaction_type": "S",
      "shares_after_transaction": "8832"
    },
    {
      "id": 91666,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-03-04",
      "transaction_shares": "1750",
      "transaction_price": "260.88",
      "transaction_type": "S",
      "shares_after_transaction": "8832"
    },
    {
      "id": 116321,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-03-04",
      "transaction_shares": "1750",
      "transaction_price": "260.88",
      "transaction_type": "S",
      "shares_after_transaction": "8832"
    },
    {
      "id": 142865,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-03-04",
      "transaction_shares": "1750",
      "transaction_price": "260.88",
      "transaction_type": "S",
      "shares_after_transaction": "8832"
    },
    {
      "id": 171470,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-03-04",
      "transaction_shares": "1750",
      "transaction_price": "260.88",
      "transaction_type": "S",
      "shares_after_transaction": "8832"
    },
    {
      "id": 202631,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-03-04",
      "transaction_shares": "1750",
      "transaction_price": "260.88",
      "transaction_type": "S",
      "shares_after_transaction": "8832"
    },
    {
      "id": 236119,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-03-04",
      "transaction_shares": "1750",
      "transaction_price": "260.88",
      "transaction_type": "S",
      "shares_after_transaction": "8832"
    },
    {
      "id": 272645,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-03-04",
      "transaction_shares": "1750",
      "transaction_price": "260.88",
      "transaction_type": "S",
      "shares_after_transaction": "8832"
    },
    {
      "id": 6610,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-29",
      "transaction_shares": "3686",
      "transaction_price": "253.43",
      "transaction_type": "S",
      "shares_after_transaction": "4792"
    },
    {
      "id": 6612,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-02-29",
      "transaction_shares": "5000",
      "transaction_price": "253.70",
      "transaction_type": "S",
      "shares_after_transaction": "13550"
    },
    {
      "id": 17540,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-29",
      "transaction_shares": "3686",
      "transaction_price": "253.43",
      "transaction_type": "S",
      "shares_after_transaction": "4792"
    },
    {
      "id": 17542,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-02-29",
      "transaction_shares": "5000",
      "transaction_price": "253.70",
      "transaction_type": "S",
      "shares_after_transaction": "13550"
    },
    {
      "id": 31251,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-29",
      "transaction_shares": "3686",
      "transaction_price": "253.43",
      "transaction_type": "S",
      "shares_after_transaction": "4792"
    },
    {
      "id": 31258,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-02-29",
      "transaction_shares": "5000",
      "transaction_price": "253.70",
      "transaction_type": "S",
      "shares_after_transaction": "13550"
    },
    {
      "id": 48968,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-29",
      "transaction_shares": "3686",
      "transaction_price": "253.43",
      "transaction_type": "S",
      "shares_after_transaction": "4792"
    },
    {
      "id": 48979,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-02-29",
      "transaction_shares": "5000",
      "transaction_price": "253.70",
      "transaction_type": "S",
      "shares_after_transaction": "13550"
    },
    {
      "id": 69234,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-29",
      "transaction_shares": "3686",
      "transaction_price": "253.43",
      "transaction_type": "S",
      "shares_after_transaction": "4792"
    },
    {
      "id": 69245,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-02-29",
      "transaction_shares": "5000",
      "transaction_price": "253.70",
      "transaction_type": "S",
      "shares_after_transaction": "13550"
    },
    {
      "id": 91669,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-29",
      "transaction_shares": "3686",
      "transaction_price": "253.43",
      "transaction_type": "S",
      "shares_after_transaction": "4792"
    },
    {
      "id": 91680,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-02-29",
      "transaction_shares": "5000",
      "transaction_price": "253.70",
      "transaction_type": "S",
      "shares_after_transaction": "13550"
    },
    {
      "id": 116324,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-29",
      "transaction_shares": "3686",
      "transaction_price": "253.43",
      "transaction_type": "S",
      "shares_after_transaction": "4792"
    },
    {
      "id": 116335,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-02-29",
      "transaction_shares": "5000",
      "transaction_price": "253.70",
      "transaction_type": "S",
      "shares_after_transaction": "13550"
    },
    {
      "id": 142868,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-29",
      "transaction_shares": "3686",
      "transaction_price": "253.43",
      "transaction_type": "S",
      "shares_after_transaction": "4792"
    },
    {
      "id": 142879,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-02-29",
      "transaction_shares": "5000",
      "transaction_price": "253.70",
      "transaction_type": "S",
      "shares_after_transaction": "13550"
    },
    {
      "id": 171473,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-29",
      "transaction_shares": "3686",
      "transaction_price": "253.43",
      "transaction_type": "S",
      "shares_after_transaction": "4792"
    },
    {
      "id": 171485,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-02-29",
      "transaction_shares": "5000",
      "transaction_price": "253.70",
      "transaction_type": "S",
      "shares_after_transaction": "13550"
    },
    {
      "id": 202634,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-29",
      "transaction_shares": "3686",
      "transaction_price": "253.43",
      "transaction_type": "S",
      "shares_after_transaction": "4792"
    },
    {
      "id": 202646,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-02-29",
      "transaction_shares": "5000",
      "transaction_price": "253.70",
      "transaction_type": "S",
      "shares_after_transaction": "13550"
    },
    {
      "id": 236122,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-29",
      "transaction_shares": "3686",
      "transaction_price": "253.43",
      "transaction_type": "S",
      "shares_after_transaction": "4792"
    },
    {
      "id": 236134,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-02-29",
      "transaction_shares": "5000",
      "transaction_price": "253.70",
      "transaction_type": "S",
      "shares_after_transaction": "13550"
    },
    {
      "id": 272648,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-29",
      "transaction_shares": "3686",
      "transaction_price": "253.43",
      "transaction_type": "S",
      "shares_after_transaction": "4792"
    },
    {
      "id": 272663,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-02-29",
      "transaction_shares": "5000",
      "transaction_price": "253.70",
      "transaction_type": "S",
      "shares_after_transaction": "13550"
    },
    {
      "id": 6615,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-02-22",
      "transaction_shares": "4050",
      "transaction_price": "248.50",
      "transaction_type": "S",
      "shares_after_transaction": "22879"
    },
    {
      "id": 17545,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-02-22",
      "transaction_shares": "4050",
      "transaction_price": "248.50",
      "transaction_type": "S",
      "shares_after_transaction": "22879"
    },
    {
      "id": 31268,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-02-22",
      "transaction_shares": "4050",
      "transaction_price": "248.50",
      "transaction_type": "S",
      "shares_after_transaction": "22879"
    },
    {
      "id": 48993,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-02-22",
      "transaction_shares": "4050",
      "transaction_price": "248.50",
      "transaction_type": "S",
      "shares_after_transaction": "22879"
    },
    {
      "id": 69259,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-02-22",
      "transaction_shares": "4050",
      "transaction_price": "248.50",
      "transaction_type": "S",
      "shares_after_transaction": "22879"
    },
    {
      "id": 91695,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-02-22",
      "transaction_shares": "4050",
      "transaction_price": "248.50",
      "transaction_type": "S",
      "shares_after_transaction": "22879"
    },
    {
      "id": 116350,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-02-22",
      "transaction_shares": "4050",
      "transaction_price": "248.50",
      "transaction_type": "S",
      "shares_after_transaction": "22879"
    },
    {
      "id": 142894,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-02-22",
      "transaction_shares": "4050",
      "transaction_price": "248.50",
      "transaction_type": "S",
      "shares_after_transaction": "22879"
    },
    {
      "id": 171502,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-02-22",
      "transaction_shares": "4050",
      "transaction_price": "248.50",
      "transaction_type": "S",
      "shares_after_transaction": "22879"
    },
    {
      "id": 202663,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-02-22",
      "transaction_shares": "4050",
      "transaction_price": "248.50",
      "transaction_type": "S",
      "shares_after_transaction": "22879"
    },
    {
      "id": 236151,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-02-22",
      "transaction_shares": "4050",
      "transaction_price": "248.50",
      "transaction_type": "S",
      "shares_after_transaction": "22879"
    },
    {
      "id": 272682,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-02-22",
      "transaction_shares": "4050",
      "transaction_price": "248.50",
      "transaction_type": "S",
      "shares_after_transaction": "22879"
    },
    {
      "id": 663,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4000",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "224613"
    },
    {
      "id": 6600,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4000",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "224613"
    },
    {
      "id": 17530,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4000",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "224613"
    },
    {
      "id": 31240,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4000",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "224613"
    },
    {
      "id": 48946,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4000",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "224613"
    },
    {
      "id": 69212,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4000",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "224613"
    },
    {
      "id": 91645,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4000",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "224613"
    },
    {
      "id": 116300,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4000",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "224613"
    },
    {
      "id": 142844,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4000",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "224613"
    },
    {
      "id": 171449,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4000",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "224613"
    },
    {
      "id": 202610,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4000",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "224613"
    },
    {
      "id": 236098,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4000",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "224613"
    },
    {
      "id": 272619,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-02-16",
      "transaction_shares": "4000",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "224613"
    },
    {
      "id": 666,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-02-15",
      "transaction_shares": "838",
      "transaction_price": "238.93",
      "transaction_type": "S",
      "shares_after_transaction": "24620"
    },
    {
      "id": 667,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "424",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "47691"
    },
    {
      "id": 672,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-15",
      "transaction_shares": "291",
      "transaction_price": "237.20",
      "transaction_type": "S",
      "shares_after_transaction": "8187"
    },
    {
      "id": 6604,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-02-15",
      "transaction_shares": "838",
      "transaction_price": "238.93",
      "transaction_type": "S",
      "shares_after_transaction": "24620"
    },
    {
      "id": 6605,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "424",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "47691"
    },
    {
      "id": 6613,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-15",
      "transaction_shares": "291",
      "transaction_price": "237.20",
      "transaction_type": "S",
      "shares_after_transaction": "8187"
    },
    {
      "id": 17534,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-02-15",
      "transaction_shares": "838",
      "transaction_price": "238.93",
      "transaction_type": "S",
      "shares_after_transaction": "24620"
    },
    {
      "id": 17535,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "424",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "47691"
    },
    {
      "id": 17543,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-15",
      "transaction_shares": "291",
      "transaction_price": "237.20",
      "transaction_type": "S",
      "shares_after_transaction": "8187"
    },
    {
      "id": 31244,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-02-15",
      "transaction_shares": "838",
      "transaction_price": "238.93",
      "transaction_type": "S",
      "shares_after_transaction": "24620"
    },
    {
      "id": 31245,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "424",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "47691"
    },
    {
      "id": 31259,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-15",
      "transaction_shares": "291",
      "transaction_price": "237.20",
      "transaction_type": "S",
      "shares_after_transaction": "8187"
    },
    {
      "id": 48956,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-02-15",
      "transaction_shares": "838",
      "transaction_price": "238.93",
      "transaction_type": "S",
      "shares_after_transaction": "24620"
    },
    {
      "id": 48960,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "424",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "47691"
    },
    {
      "id": 48982,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-15",
      "transaction_shares": "291",
      "transaction_price": "237.20",
      "transaction_type": "S",
      "shares_after_transaction": "8187"
    },
    {
      "id": 69222,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-02-15",
      "transaction_shares": "838",
      "transaction_price": "238.93",
      "transaction_type": "S",
      "shares_after_transaction": "24620"
    },
    {
      "id": 69226,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "424",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "47691"
    },
    {
      "id": 69248,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-15",
      "transaction_shares": "291",
      "transaction_price": "237.20",
      "transaction_type": "S",
      "shares_after_transaction": "8187"
    },
    {
      "id": 91656,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-02-15",
      "transaction_shares": "838",
      "transaction_price": "238.93",
      "transaction_type": "S",
      "shares_after_transaction": "24620"
    },
    {
      "id": 91661,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "424",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "47691"
    },
    {
      "id": 91683,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-15",
      "transaction_shares": "291",
      "transaction_price": "237.20",
      "transaction_type": "S",
      "shares_after_transaction": "8187"
    },
    {
      "id": 116311,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-02-15",
      "transaction_shares": "838",
      "transaction_price": "238.93",
      "transaction_type": "S",
      "shares_after_transaction": "24620"
    },
    {
      "id": 116316,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "424",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "47691"
    },
    {
      "id": 116338,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-15",
      "transaction_shares": "291",
      "transaction_price": "237.20",
      "transaction_type": "S",
      "shares_after_transaction": "8187"
    },
    {
      "id": 142855,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-02-15",
      "transaction_shares": "838",
      "transaction_price": "238.93",
      "transaction_type": "S",
      "shares_after_transaction": "24620"
    },
    {
      "id": 142860,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "424",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "47691"
    },
    {
      "id": 142882,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-15",
      "transaction_shares": "291",
      "transaction_price": "237.20",
      "transaction_type": "S",
      "shares_after_transaction": "8187"
    },
    {
      "id": 171460,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-02-15",
      "transaction_shares": "838",
      "transaction_price": "238.93",
      "transaction_type": "S",
      "shares_after_transaction": "24620"
    },
    {
      "id": 171465,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "424",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "47691"
    },
    {
      "id": 171489,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-15",
      "transaction_shares": "291",
      "transaction_price": "237.20",
      "transaction_type": "S",
      "shares_after_transaction": "8187"
    },
    {
      "id": 202621,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-02-15",
      "transaction_shares": "838",
      "transaction_price": "238.93",
      "transaction_type": "S",
      "shares_after_transaction": "24620"
    },
    {
      "id": 202626,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "424",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "47691"
    },
    {
      "id": 202650,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-15",
      "transaction_shares": "291",
      "transaction_price": "237.20",
      "transaction_type": "S",
      "shares_after_transaction": "8187"
    },
    {
      "id": 236109,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-02-15",
      "transaction_shares": "838",
      "transaction_price": "238.93",
      "transaction_type": "S",
      "shares_after_transaction": "24620"
    },
    {
      "id": 236114,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "424",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "47691"
    },
    {
      "id": 236138,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-15",
      "transaction_shares": "291",
      "transaction_price": "237.20",
      "transaction_type": "S",
      "shares_after_transaction": "8187"
    },
    {
      "id": 272633,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-02-15",
      "transaction_shares": "838",
      "transaction_price": "238.93",
      "transaction_type": "S",
      "shares_after_transaction": "24620"
    },
    {
      "id": 272640,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-02-15",
      "transaction_shares": "424",
      "transaction_price": "0",
      "transaction_type": "G",
      "shares_after_transaction": "47691"
    },
    {
      "id": 272668,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-02-15",
      "transaction_shares": "291",
      "transaction_price": "237.20",
      "transaction_type": "S",
      "shares_after_transaction": "8187"
    },
    {
      "id": 668,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kemps-Polanco Reshema",
      "reporting_owner_cik": "0002009357",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "170",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "170"
    },
    {
      "id": 6606,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kemps-Polanco Reshema",
      "reporting_owner_cik": "0002009357",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "170",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "170"
    },
    {
      "id": 17536,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kemps-Polanco Reshema",
      "reporting_owner_cik": "0002009357",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "170",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "170"
    },
    {
      "id": 31246,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kemps-Polanco Reshema",
      "reporting_owner_cik": "0002009357",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "170",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "170"
    },
    {
      "id": 48961,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kemps-Polanco Reshema",
      "reporting_owner_cik": "0002009357",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "170",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "170"
    },
    {
      "id": 69227,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kemps-Polanco Reshema",
      "reporting_owner_cik": "0002009357",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "170",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "170"
    },
    {
      "id": 91662,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kemps-Polanco Reshema",
      "reporting_owner_cik": "0002009357",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "170",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "170"
    },
    {
      "id": 116317,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kemps-Polanco Reshema",
      "reporting_owner_cik": "0002009357",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "170",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "170"
    },
    {
      "id": 142861,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kemps-Polanco Reshema",
      "reporting_owner_cik": "0002009357",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "170",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "170"
    },
    {
      "id": 171466,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kemps-Polanco Reshema",
      "reporting_owner_cik": "0002009357",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "170",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "170"
    },
    {
      "id": 202627,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kemps-Polanco Reshema",
      "reporting_owner_cik": "0002009357",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "170",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "170"
    },
    {
      "id": 236115,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kemps-Polanco Reshema",
      "reporting_owner_cik": "0002009357",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "170",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "170"
    },
    {
      "id": 272641,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Kemps-Polanco Reshema",
      "reporting_owner_cik": "0002009357",
      "reporting_owner_position": null,
      "transaction_date": "2024-02-01",
      "transaction_shares": "170",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "170"
    },
    {
      "id": 661,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2115",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8967"
    },
    {
      "id": 662,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "19503"
    },
    {
      "id": 664,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "24253",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "239370"
    },
    {
      "id": 665,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12100"
    },
    {
      "id": 669,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3526",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "49274"
    },
    {
      "id": 670,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "17436",
      "transaction_price": "144.67",
      "transaction_type": "M",
      "shares_after_transaction": "227827"
    },
    {
      "id": 671,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "968",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10908"
    },
    {
      "id": 673,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3350",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "26483"
    },
    {
      "id": 6598,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2115",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8967"
    },
    {
      "id": 6599,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "19503"
    },
    {
      "id": 6601,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "24253",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "239370"
    },
    {
      "id": 6602,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12100"
    },
    {
      "id": 6607,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3526",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "49274"
    },
    {
      "id": 6608,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "17436",
      "transaction_price": "144.67",
      "transaction_type": "M",
      "shares_after_transaction": "227827"
    },
    {
      "id": 6611,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "968",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10908"
    },
    {
      "id": 6614,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3350",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "26483"
    },
    {
      "id": 17528,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2115",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8967"
    },
    {
      "id": 17529,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "19503"
    },
    {
      "id": 17531,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "24253",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "239370"
    },
    {
      "id": 17532,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12100"
    },
    {
      "id": 17537,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3526",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "49274"
    },
    {
      "id": 17538,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "17436",
      "transaction_price": "144.67",
      "transaction_type": "M",
      "shares_after_transaction": "227827"
    },
    {
      "id": 17541,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "968",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10908"
    },
    {
      "id": 17544,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3350",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "26483"
    },
    {
      "id": 31238,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2115",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8967"
    },
    {
      "id": 31239,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "19503"
    },
    {
      "id": 31241,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "24253",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "239370"
    },
    {
      "id": 31242,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12100"
    },
    {
      "id": 31247,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3526",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "49274"
    },
    {
      "id": 31248,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "17436",
      "transaction_price": "144.67",
      "transaction_type": "M",
      "shares_after_transaction": "227827"
    },
    {
      "id": 31252,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "968",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10908"
    },
    {
      "id": 31266,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3350",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "26483"
    },
    {
      "id": 48943,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2115",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8967"
    },
    {
      "id": 48944,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "19503"
    },
    {
      "id": 48948,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "24253",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "239370"
    },
    {
      "id": 48952,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12100"
    },
    {
      "id": 48963,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3526",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "49274"
    },
    {
      "id": 48964,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "17436",
      "transaction_price": "144.67",
      "transaction_type": "M",
      "shares_after_transaction": "227827"
    },
    {
      "id": 48969,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "968",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10908"
    },
    {
      "id": 48991,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3350",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "26483"
    },
    {
      "id": 69209,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2115",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8967"
    },
    {
      "id": 69210,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "19503"
    },
    {
      "id": 69214,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "24253",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "239370"
    },
    {
      "id": 69218,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12100"
    },
    {
      "id": 69229,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3526",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "49274"
    },
    {
      "id": 69230,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "17436",
      "transaction_price": "144.67",
      "transaction_type": "M",
      "shares_after_transaction": "227827"
    },
    {
      "id": 69235,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "968",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10908"
    },
    {
      "id": 69257,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3350",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "26483"
    },
    {
      "id": 91642,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2115",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8967"
    },
    {
      "id": 91643,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "19503"
    },
    {
      "id": 91647,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "24253",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "239370"
    },
    {
      "id": 91652,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12100"
    },
    {
      "id": 91664,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3526",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "49274"
    },
    {
      "id": 91665,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "17436",
      "transaction_price": "144.67",
      "transaction_type": "M",
      "shares_after_transaction": "227827"
    },
    {
      "id": 91670,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "968",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10908"
    },
    {
      "id": 91692,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3350",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "26483"
    },
    {
      "id": 116297,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2115",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8967"
    },
    {
      "id": 116298,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "19503"
    },
    {
      "id": 116302,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "24253",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "239370"
    },
    {
      "id": 116307,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12100"
    },
    {
      "id": 116319,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3526",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "49274"
    },
    {
      "id": 116320,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "17436",
      "transaction_price": "144.67",
      "transaction_type": "M",
      "shares_after_transaction": "227827"
    },
    {
      "id": 116325,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "968",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10908"
    },
    {
      "id": 116347,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3350",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "26483"
    },
    {
      "id": 142841,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2115",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8967"
    },
    {
      "id": 142842,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "19503"
    },
    {
      "id": 142846,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "24253",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "239370"
    },
    {
      "id": 142851,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12100"
    },
    {
      "id": 142863,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3526",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "49274"
    },
    {
      "id": 142864,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "17436",
      "transaction_price": "144.67",
      "transaction_type": "M",
      "shares_after_transaction": "227827"
    },
    {
      "id": 142869,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "968",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10908"
    },
    {
      "id": 142891,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3350",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "26483"
    },
    {
      "id": 171446,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2115",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8967"
    },
    {
      "id": 171447,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "19503"
    },
    {
      "id": 171451,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "24253",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "239370"
    },
    {
      "id": 171456,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12100"
    },
    {
      "id": 171468,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3526",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "49274"
    },
    {
      "id": 171469,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "17436",
      "transaction_price": "144.67",
      "transaction_type": "M",
      "shares_after_transaction": "227827"
    },
    {
      "id": 171474,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "968",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10908"
    },
    {
      "id": 171499,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3350",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "26483"
    },
    {
      "id": 202607,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2115",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8967"
    },
    {
      "id": 202608,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "19503"
    },
    {
      "id": 202612,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "24253",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "239370"
    },
    {
      "id": 202617,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12100"
    },
    {
      "id": 202629,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3526",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "49274"
    },
    {
      "id": 202630,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "17436",
      "transaction_price": "144.67",
      "transaction_type": "M",
      "shares_after_transaction": "227827"
    },
    {
      "id": 202635,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "968",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10908"
    },
    {
      "id": 202660,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3350",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "26483"
    },
    {
      "id": 236095,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2115",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8967"
    },
    {
      "id": 236096,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "19503"
    },
    {
      "id": 236100,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "24253",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "239370"
    },
    {
      "id": 236105,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12100"
    },
    {
      "id": 236117,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3526",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "49274"
    },
    {
      "id": 236118,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "17436",
      "transaction_price": "144.67",
      "transaction_type": "M",
      "shares_after_transaction": "227827"
    },
    {
      "id": 236123,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "968",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10908"
    },
    {
      "id": 236148,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3350",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "26483"
    },
    {
      "id": 272616,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Parisotto Shannon M",
      "reporting_owner_cik": "0001952784",
      "reporting_owner_position": "CEVP, Disc & Safety Assessment",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2115",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "8967"
    },
    {
      "id": 272617,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Creamer Victoria L",
      "reporting_owner_cik": "0001632780",
      "reporting_owner_position": "EVP & Chief People Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "19503"
    },
    {
      "id": 272621,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "24253",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "239370"
    },
    {
      "id": 272628,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Barbo William D",
      "reporting_owner_cik": "0001688104",
      "reporting_owner_position": "Corporate Executive VP & CCO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "2997",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "12100"
    },
    {
      "id": 272643,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Girshick Birgit",
      "reporting_owner_cik": "0001732091",
      "reporting_owner_position": "Corporate Executive VP & COO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3526",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "49274"
    },
    {
      "id": 272644,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "FOSTER JAMES C",
      "reporting_owner_cik": "0001141722",
      "reporting_owner_position": "Chairman, President and CEO",
      "transaction_date": "2024-01-29",
      "transaction_shares": "17436",
      "transaction_price": "144.67",
      "transaction_type": "M",
      "shares_after_transaction": "227827"
    },
    {
      "id": 272649,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "Knell Michael Gunnar",
      "reporting_owner_cik": "0001543779",
      "reporting_owner_position": "CSVP&Chief Accounting Officer",
      "transaction_date": "2024-01-29",
      "transaction_shares": "968",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "10908"
    },
    {
      "id": 272679,
      "issuer_name": "CHARLES RIVER LABORATORIES INTERNATIONAL, INC.",
      "reporting_owner": "LaPlume Joseph W",
      "reporting_owner_cik": "0001767215",
      "reporting_owner_position": "EVP, Corp Strategy & Develop",
      "transaction_date": "2024-01-29",
      "transaction_shares": "3350",
      "transaction_price": "0",
      "transaction_type": "A",
      "shares_after_transaction": "26483"
    }
  ]
}